CAV1 and cardiomyopathy: Other studies revealed that in addition to ERK1/2 signaling, the negative regulation of eNOS by caveolin-1, which results in constitutive hyperactivation of the nitric oxide pathway in caveolin-1-knockout mice, is also involved in the development of severe cardiomyopathy and impaired pump function [43, 44].